<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592656</url>
  </required_header>
  <id_info>
    <org_study_id>FLUI-2010-68</org_study_id>
    <nct_id>NCT01592656</nct_id>
  </id_info>
  <brief_title>Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
  <official_title>Long-term Effects of Non-invasive Ventilation in Hypercapnic COPD Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FLUIDDA nv</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FLUIDDA nv</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this multicenter study the comparison of the mass flow distribution and redistribution
      versus the relative blood flow per lobe (as a surrogate for Ventilation/ Perfusion (V/Q)
      matching) with functional respiratory imaging (FRI) and arterial blood gas (ABG) values will
      be evaluated in hypercapnic Chronic Obstructive Pulmonary Disease (COPD) patients. Therefore
      a low dose Computed Tomography (CT) scan will be taken in a population of 30 patients with
      non-invasive ventilation (NIV) and in a control group of 10 patients without NIV. The CT-scan
      will be used for FRI.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of budget
  </why_stopped>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the distribution of the mass flow per lobe and the relative proportion of bloodvessels, as obtained from functional respiratory imaging (FRI) and arterial blood gas (ABG).</measure>
    <time_frame>At baseline, after 1 month and after 6 months of treatment with non-invasive ventilation (NIV)</time_frame>
    <description>The primary objective of this study is the comparison of the mass flow distribution and redistribution versus the relative blood flow per lobe (as a surrogate for V/Q matching) with FRI and ABG values in hypercapnic COPD patients treated with long-term NIV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>At baseline, after 1 month and after 6 months</time_frame>
    <description>Saint George's Respiratory Questionnaire (SGRQ) and Severe Respiratory Insufficiency (SRI) Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function tests</measure>
    <time_frame>At baseline, after 1 month and after 6 months</time_frame>
    <description>Spirometry, reversibility, plethysmography, diffusion, Maximal Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital admissions</measure>
    <time_frame>After 1 month and after 6 months</time_frame>
    <description>Length and frequency of admission, severity of exacerbations, ICU admissions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise tolerance</measure>
    <time_frame>At baseline, after 1 month and after 6 months</time_frame>
    <description>6 minutes walking test and oximetry measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local airway volume and resistance</measure>
    <time_frame>At baseline, after 1 month and after 6 months</time_frame>
    <description>CT-scan of thorax. CT scan is performed with a low radiation protocol. These images are made to perform computational fluid dynamics on in order to obtain more information on regional lung function characteristics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of breathing pattern</measure>
    <time_frame>At baseline</time_frame>
    <description>The tertiary objective of the study is to predict the breathing pattern (including tidal volume) during NIV when using the data of patient specific lobar compliance and regional resistance at baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Non-invasive ventilation (NIV)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 patients will receive NIV during 6 months = group 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 patients will act as control group, they will not be treated with NIV = group 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Functional Respiratory Imaging</intervention_name>
    <description>CT-scan of thorax. At baseline, after 1 month and after 6 months.</description>
    <arm_group_label>Non-invasive ventilation (NIV)</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lung compliance measurement</intervention_name>
    <description>At baseline</description>
    <arm_group_label>Non-invasive ventilation (NIV)</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-invasive ventilation (Respironics)</intervention_name>
    <description>Long-term non-invasive ventilation, starting at baseline until 6 months. At baseline the patients should have persisting hypercapnia (pCO2 &gt; 45 mmHg) under optimal conservative treatment other than NIV. The patients can be hospitalised or being treated at home at inclusion.</description>
    <arm_group_label>Non-invasive ventilation (NIV)</arm_group_label>
    <other_name>Trilogy device (Respironics)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: â‰¥ 40 years old

          -  Men and women

          -  Written informed consent obtained

          -  COPD patients GOLD II, III and IV

          -  Persisting hypercapnia (pCO2 &gt; 45 mmHg ) notwithstanding adequate treatment modalities
             (including oxygen) as proposed by the GOLD guidelines

          -  Stopped smoking

          -  Total lung capacity (TLC) &gt; 85%

        Exclusion Criteria:

          -  Treatment with home NIV or Continuous Positive Airway Pressure (CPAP)

          -  Asthma

          -  Restrictive lung disease

          -  Symptomatic or uncontrolled heart failure

          -  Current malignancy

          -  Suspected bad compliance for NIV treatment

          -  Pregnant women

          -  Not be able to speak the language of the participating center

          -  Received an investigational product within 4 weeks prior to inclusion in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried De Backer, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Antwerp</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Wijkstra, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2012</study_first_submitted>
  <study_first_submitted_qc>May 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>January 15, 2014</last_update_submitted>
  <last_update_submitted_qc>January 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>GOLD stages II, III and IV</keyword>
  <keyword>Computed Tomography scan</keyword>
  <keyword>Functional Respiratory Imaging</keyword>
  <keyword>Non-Invasive Ventilation</keyword>
  <keyword>Arterial Blood Gas</keyword>
  <keyword>Hypercapnic</keyword>
  <keyword>Health Related Quality of Life</keyword>
  <keyword>Lung compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

